Natura Bioscience Marketing Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-06-2024
- Paid Up Capital ₹ 0.10 M
as on 25-06-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
- Revenue -3.84%
(FY 2016)
- Profit -20.52%
(FY 2016)
- Ebitda 62.82%
(FY 2016)
- Net Worth 30.29%
(FY 2016)
- Total Assets 21.91%
(FY 2016)
About Natura Bioscience Marketing
The Corporate was formerly known as Bsy Marketing India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kizhakkeillom Rajesh and Josephvattakkunnel Joseph serve as directors at the Company.
- CIN/LLPIN
U51909KL2011PTC028178
- Company No.
028178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2011
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Natura Bioscience Marketing?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Josephvattakkunnel Joseph  | Managing Director | 19-Apr-2011 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kizhakkeillom Rajesh | Whole-Time Director | 13-Jun-2011 | Current |
Financial Performance and Corporate Structure Insights of Natura Bioscience Marketing.
Natura Bioscience Marketing Private Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 3.84% decrease. The company also saw a substantial fall in profitability, with a 20.52% decrease in profit. The company's net worth Soared by an impressive increase of 30.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natura Bioscience Marketing?
In 2016, Natura Bioscience Marketing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Natura Bioscience Industries Private LimitedActive 11 years 2 monthsKizhakkeillom Rajesh and Josephvattakkunnel Joseph are mutual person
- Gois Software Labs Private LimitedActive 9 years 19 days
Kizhakkeillom Rajesh and Josephvattakkunnel Joseph are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Natura Bioscience Marketing?
Unlock and access historical data on people associated with Natura Bioscience Marketing, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natura Bioscience Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natura Bioscience Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
